How to Lose Weight With PCOS: What Actually Works

With PCOS, weight loss is harder but not different in kind. A calorie deficit works, and no single "PCOS diet" has beaten the others in trials. Metformin adds a little. GLP-1 medicines add the most, and the 2023 international PCOS guideline lists them as an option for adults. Once weight comes down, periods and ovulation often return, so plan contraception.

Below, each option comes with the strength of the evidence behind it, so you can see where your effort and money go furthest.

Why is it harder to lose weight with PCOS?

Polycystic ovary syndrome is a hormonal and metabolic condition, not only an ovarian one. Most women with it have some degree of insulin resistance: the body needs more insulin than usual to move glucose into cells, and that extra insulin pushes the ovaries to make more androgens and makes fat easier to store, especially around the middle¹. That is why the same eating and exercise habits can move the scale more slowly for you than for a friend without PCOS.

The condition is also getting a new name. In May 2026 a global consensus published in The Lancet renamed it polyendocrine metabolic ovarian syndrome, or PMOS, because the old name points at ovarian "cysts" that are not really cysts and hides the metabolic side of the condition². A transition period is under way, so most clinics, insurers and lab reports still say PCOS. This guide uses PCOS because that is still what you will see on your chart.

The international guideline that most PCOS care in the US now follows was published in 2023 and drew on 52 systematic reviews¹. It is candid that much of the evidence is low to moderate quality. That matters for the table below: some popular options rest on thin evidence, and the guideline says so.

What works for PCOS weight, ranked by evidence

The guideline grades how strongly it recommends something separately from how sure the evidence is. "Strong recommendation, low-certainty evidence" means the panel is confident lifestyle care helps, even though the individual trials are small¹.

Is there a best diet for PCOS?

No. The guideline says plainly that there is no evidence to support any one type of diet composition over another for women with PCOS, and that any eating pattern consistent with general healthy-eating guidance will have health benefits¹. Low-carb, Mediterranean, high-protein, intermittent fasting: each can work if it creates a calorie deficit you can sustain. None has a PCOS-specific advantage that shows up consistently in trials.

What the guideline does recommend is a tailored calorie deficit if weight loss is the goal, built around your preferences rather than a fixed menu¹. In practice, that means choosing the pattern you can still follow in six months.

It is also honest about how much lifestyle change alone delivers on average. A Cochrane review of 15 trials in women with PCOS found lifestyle programs reduced weight by about 1.7 kg (roughly 3.7 pounds) more than minimal or no treatment, and also lowered the free androgen index, a measure of active testosterone³. That is a real effect, and for some women it is enough to change symptoms, but it explains why so many women with PCOS feel they are doing everything right and seeing little.

Two cautions belong here. First, disordered eating is more common in PCOS, and the guideline asks clinicians to consider it at any weight, especially during a weight-loss program¹. If dieting has a history of tipping into restriction or bingeing for you, say so before you start. Second, the guideline names weight stigma in health care as a real problem and asks clinicians to offer the same quality of care regardless of weight¹. You are entitled to that.

How much does exercise help with PCOS?

Exercise on its own moves the scale only modestly, but it improves insulin sensitivity, central fat and mood, and the guideline is explicit that a healthy lifestyle has benefits even when weight does not change¹.

The targets are the general adult ones: at least 150 to 300 minutes a week of moderate activity, or 75 to 150 minutes of vigorous activity, plus muscle-strengthening work on two non-consecutive days. For modest weight loss and to prevent regain, the guideline points to at least 250 minutes a week of moderate activity¹. Strength training deserves its place on the list for a second reason: if you go on to use a GLP-1 medicine, keeping muscle while losing fat becomes a priority, which our guide to muscle loss on GLP-1s covers.

Does metformin help you lose weight with PCOS?

A little. Metformin is an insulin-sensitizing diabetes drug that many women with PCOS are offered first. The guideline says it should be considered in adults with PCOS and a BMI of 25 or higher for weight and metabolic outcomes, and that it may be considered at lower BMIs, while telling women that metformin and an active lifestyle program have similar effects¹.

In a meta-analysis of 12 trials, adding metformin to lifestyle change lowered BMI by about 0.7 points more than lifestyle change alone over six months, reduced fat under the skin and increased the number of menstrual cycles⁴. Metformin alone produced similar weight to lifestyle change alone. A later review done for the 2023 guideline concluded that metformin should remain the first-line insulin sensitizer for weight and metabolic features in PCOS⁵.

Side effects are mostly stomach upset that eases with time. Starting low, raising the dose in 500 mg steps or using an extended-release form helps, and long-term users may need their vitamin B12 checked¹. Metformin is inexpensive and widely covered, which is a real advantage. Just set expectations: it is a helper, not a weight-loss drug on the scale of a GLP-1.

Does inositol work for PCOS weight loss?

The evidence is weak. Inositol (myo-inositol, D-chiro-inositol or a blend) is one of the most marketed PCOS supplements, sold on the idea that it improves insulin sensitivity. A systematic review done for the 2023 guideline pooled 30 trials and found possible benefits for some metabolic measures and, for D-chiro-inositol, possibly ovulation. It found no clear effect on most other outcomes, and evidence on BMI it called very uncertain. Its overall conclusion: the evidence is limited and inconclusive⁶.

The guideline lands in the same place. Inositol could be considered based on personal preference, specific types, doses or combinations cannot be recommended, and metformin should be preferred over inositol for central fat¹. Inositol is generally well tolerated, so trying it is not dangerous. It is simply not where the weight results are, and it should not delay a conversation about treatments with stronger evidence.

Do GLP-1 medicines work for PCOS?

They have the largest effect of any option on this list. The 2023 guideline is the first international PCOS guideline to say anti-obesity medicines, naming liraglutide and semaglutide, could be considered alongside lifestyle care for adults with PCOS and higher weight¹. It adds three practical points: use effective contraception when pregnancy is possible, raise the dose gradually to limit stomach side effects, and expect a high risk of weight regain if the medicine is stopped¹.

The PCOS-specific trials are small. The review that informed the guideline found only 11 trials of anti-obesity medicines in PCOS, with liraglutide, semaglutide and orlistat looking better than placebo on weight, and it called the published data very limited⁷. The best-controlled PCOS trial randomized 82 women to liraglutide 3 mg or placebo for 32 weeks: weight fell 5.7% on liraglutide against 1.4% on placebo, and the free androgen index fell too⁸. Stomach side effects, mostly mild to moderate, affected 58% of women on the drug.

For semaglutide, the PCOS data are observational. In 27 women with PCOS who had not lost weight on a lifestyle program, low-dose semaglutide (0.5 mg weekly) produced an average loss of 7.6 kg in three months, and among those who kept going, 11.5 kg at six months, with menstrual cycles normalizing in 80% of responders⁹. A larger follow-up by the same team in 96 women found an average loss of 11.3% at six months, with ovulation returning in about half of women who had not been ovulating¹⁰. These studies had no placebo group, so treat the numbers as encouraging rather than settled.

The size of the effect you can expect comes mostly from the big obesity trials, which were not PCOS-specific but enrolled mostly women: about 15% average weight loss on semaglutide 2.4 mg over 68 weeks in STEP 1¹¹, and up to about 20% on the highest tirzepatide dose in SURMOUNT-1¹². PCOS-specific tirzepatide data are newer and smaller: a randomized trial combining it with metformin and a UK cohort study were both published in 2026, and our guide to Ozempic and Zepbound for PCOS walks through what they found. Our guide to GLP-1 medication and PCOS covers how semaglutide and tirzepatide compare for PCOS specifically, and semaglutide vs tirzepatide for women sets out the head-to-head data.

Metformin vs a GLP-1: which comes first?

Many women start on metformin because it is cheap, covered and familiar, then move to a GLP-1 if weight does not shift. That order makes sense for cost, not because metformin works better. The two can also be used together under a clinician's care. A rough way to see the difference:

Will insurance cover Ozempic or another GLP-1 for PCOS?

Usually not for PCOS itself, because no GLP-1 medicine is FDA-approved for PCOS. Ozempic is approved for type 2 diabetes. Wegovy and Zepbound are approved for chronic weight management, and Zepbound's approval covers adults with a BMI of 30 or more, or 27 or more with at least one weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol¹³. If your plan covers weight-management drugs at all, coverage is judged on those criteria, not on the PCOS diagnosis. Many plans exclude weight-loss drugs entirely.

If you are seeking coverage, ask your clinician to document your BMI, any weight-related conditions (prediabetes, high cholesterol, high blood pressure, sleep apnea) and what you have already tried. Prior-authorization forms usually ask for exactly those. If your plan says no, compounded semaglutide or tirzepatide through a telehealth program is the route many women take. It costs less than brand cash prices but is not FDA-approved, a trade-off our guide to compounded vs brand-name GLP-1s explains.

Why does sleep matter for PCOS weight?

Sleep apnea is far more common in PCOS than most women realize. A meta-analysis done for the 2023 guideline put its prevalence at about 37% in women with PCOS against 6% without it, with higher risk at higher weight¹⁴. The guideline recommends that every woman with PCOS be asked about symptoms such as snoring, waking unrefreshed and daytime sleepiness, and referred for a sleep study if they are present¹.

Poor sleep raises appetite, saps energy for exercise and makes insulin resistance worse. If you snore or wake exhausted, ask about it. Treating sleep apnea will not melt weight by itself, but it removes a drag on everything else in this guide.

Losing weight can bring ovulation back: plan for it

This is the part women are most often not told. As weight and insulin levels fall, many women with PCOS start ovulating again, sometimes after years of irregular or absent periods. In the semaglutide studies above, cycles normalized in most women who responded⁹¹⁰. That is good news if you want a pregnancy later, and a surprise if you do not.

The guideline asks clinicians to make sure you have effective contraception whenever pregnancy is possible on a GLP-1¹. GLP-1 medicines are not used during pregnancy, and some can affect how well birth-control pills are absorbed. Our guide to GLP-1s, birth control and fertility covers which methods to use and when to stop the medicine before trying to conceive. If you are planning IVF, see our guide to GLP-1 before IVF and fertility treatment.

Where to start this month

If you have not been formally assessed, start there. The guideline recommends checking glucose status and a lipid profile at diagnosis for every woman with PCOS, whatever her weight¹, and those results shape which treatments make sense. Our guide to labs and monitoring on GLP-1s lists what to ask for.

Then match the step to where you are. If you have not yet tried a structured plan, a calorie deficit you can sustain plus regular movement is the foundation. If you have, and weight has not moved, metformin is a reasonable low-cost add-on, and a GLP-1 medicine is the option with the largest effect. If you are considering a GLP-1 through telehealth, our PCOS provider board orders programs by how well they suit women managing PCOS: whether both semaglutide and tirzepatide are offered, whether labs are part of care, and how hormones are handled. For example, Enhance MD builds metabolic lab testing every six months into its program, CoreAge Rx, a featured partner, offers both molecules, each at a flat monthly price, and HealthRX adds an oral tablet for women who would rather avoid injections. None of these is a dedicated PCOS clinic, so if you want a specialist as well, our guide to finding a PCOS specialist explains who to see. For the insulin side of the picture, see insulin resistance and GLP-1s in women.

We earn a commission when you start treatment through some links on this site, at no extra cost to you. CoreAge Rx is a featured partner, and providers we work with may appear first. Educational content, not medical advice. Talk to a licensed clinician before starting any treatment.